Carbon Based Nanomaterials Drug Delivery

The use of carbon-based nanomaterials for drug delivery is an exciting and rapidly evolving field within the broader realm of nanomedicine. Carbon-based nanomaterials possess unique properties, such as high surface area, biocompatibility, and tunable surface chemistry, making them promising candidates for drug delivery applications. Here are some key points related to the content of using carbon-based nanomaterials for drug delivery:

• Carbon Nanotubes (CNTs): CNTs are cylindrical structures made of carbon atoms arranged in a hexagonal lattice. They have exceptional mechanical, thermal, and electrical properties. Functionalized CNTs can be used as carriers for drug delivery. The drugs can be attached to or encapsulated within the nanotube structure.
• Graphene and Graphene Oxide (GO): Graphene consists of a singular layer of carbon atoms organized in a two-dimensional honeycomb lattice structure. Graphene oxide is a derivative of graphene with oxygen-containing functional groups. Both graphene and graphene oxide have large surface areas and can be modified for drug loading and delivery.
• Carbon Nanoparticles: Various forms of carbon nanoparticles, including fullerenes and carbon dots, are explored for drug delivery applications. Fullerenes, such as C60, are spherical carbon structures that can encapsulate drug molecules.
• Biocompatibility and Surface Functionalization: Carbon-based nanomaterials are generally considered biocompatible, but surface functionalization is often necessary to enhance their biocompatibility and tailor their interactions with biological systems. Functional groups like hydroxyl, carboxyl, or amine can be introduced to improve solubility and biocompatibility.
• Challenges and Safety Concerns: Despite their promising properties, challenges such as potential toxicity, biodegradability, and clearance from the body need to be addressed.